Whether combination antimicrobial therapy is more efficacious than monother
apy for gram-negative bacteraemia remains controversial. Although there are
theoretical advantages to combination therapy that are buttressed by in vi
tro and animal studies, the data from studies of patients with gram-negativ
e bacteraemias have been conflicting. A review of selected clinical studies
suggests that combination therapy is associated with improved outcome typi
cally only in severely ill patients and its efficacy may be further limited
to those with Pseudomonas aeruginosa, Klebsiella spp. or Enterobacter spp.
bacteraemia. (C) 1999 Elsevier Science B.V. and International Society of C
hemotherapy. All rights reserved.